Does Presbyterian Healthcare Services Cover Mounjaro?
The verdict
Conditional on most plans
Presbyterian Healthcare Services (New Mexico) covers Mounjaro for type 2 diabetes with prior authorization — this is a composite pattern inferred from the near-universal diabetes-only baseline; verify specific criteria on the Presbyterian formulary. Mounjaro is not covered for weight loss under any line. NM Medicaid covers some weight-loss GLP-1s with PA, but that applies to the on-label weight-loss products (Wegovy, Zepbound), not Mounjaro. The weight-loss tirzepatide product is Zepbound, with separate coverage.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Presbyterian Healthcare Services using your member ID.
Key facts
Mounjaro (tirzepatide) is FDA-approved for type 2 diabetes only — not weight loss. The weight-loss tirzepatide product is Zepbound, a separate FDA approval.
FDA drug labeling, Mounjaro (tirzepatide) prescribing information
New Mexico Medicaid covers some weight-loss GLP-1s (Wegovy, Zepbound) with PA for eligible enrollees — but Mounjaro is a diabetes drug and is excluded from this weight-loss coverage.
New Mexico Human Services Department, Medicaid Preferred Drug List
The 2026 Medicare Part D out-of-pocket cap is $2,100; most continuous Mounjaro users for diabetes reach the cap within 2–3 months and pay $0 for the rest of the year.
CMS.gov, Medicare Part D Redesign 2025–2026
Medicare vs. commercial coverage
Whether Presbyterian Healthcare Services covers Mounjaro depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D covers Mounjaro for type 2 diabetes only — not weight loss — at a specialty or non-preferred tier with prior authorization. The 2026 out-of-pocket cap is $2,100; most continuous users reach it within 2–3 months and pay $0 for the rest of the year. The IRA-negotiated Medicare MFN price of $245/month begins mid-2026. Mounjaro is NOT included in the 2026 Medicare GLP-1 Bridge ($50/month, July 1, 2026 – Dec 31, 2027), which covers weight-loss-approved products only. Lilly savings card is not usable by Medicare beneficiaries. Verify your specific Presbyterian Medicare plan formulary.
Commercial / Employer
Group & marketplace plans
Commercial and employer-sponsored Presbyterian plans are expected to cover Mounjaro for type 2 diabetes with prior authorization based on the near-universal diabetes-only pattern; off-label weight-loss use (diagnosis code E66.x) is denied. Presbyterian's drug-level formulary is not as publicly detailed as national carriers — verify on the Presbyterian formulary or member services. ACA/Individual plans cover Mounjaro for T2D with PA; weight-loss GLP-1s are commonly excluded. NM Medicaid covers some weight-loss GLP-1s (Wegovy, Zepbound) with PA — this does not apply to Mounjaro, which is diabetes-only. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card (excludes government programs; expires 12/31/2026). Without coverage on a commercial plan, the card reduces cost to $499/month (max $647/month, up to 13 fills).
The 5 boxes you must tick to get approved
Commercial plans that will consider Mounjaro require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
0 of 5 requirements selected. Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Mounjaro actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
Approximately $1,300–$1,560/month retail (WAC ~$1,080). Lilly savings card: $499/month for commercially insured without coverage (max $647/month, up to 13 fills; expires 12/31/2026). Excludes all government programs.
List price with no coverage — before any manufacturer savings card.
With coverage
Varies by plan tier — not publicly published at the drug level for Presbyterian. Verify on the Presbyterian formulary or member services. Commercially insured patients with coverage may pay as little as $25/month via the Lilly savings card.
Typical monthly copay once prior authorization is approved.
Bridge program
Lilly Mounjaro Savings Card: commercially insured patients with coverage as little as $25/mo; without coverage $499/mo (up to 13 fills, expires 12/31/2026). Not available to Medicare, Medicaid, Medicare Advantage, or government program beneficiaries.
Reduced copay through the assistance program, where eligible.
All figures are estimates. Presbyterian's plan-level tier and cost-share are not publicly published — confirm directly with the plan formulary or member services. Medicare Part D: 25% coinsurance after deductible until the $2,100 OOP cap; MFN $245/month mid-2026. NM Medicaid nominal.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Contact Presbyterian directly for formulary details
Because Presbyterian's drug-level formulary details are not as publicly available as national carriers, the most reliable step is to call Presbyterian member services or log in to the member portal to search for Mounjaro (tirzepatide) by name, confirm your tier, and ask about prior authorization requirements.
- 2
Have your prescriber document the prior authorization requirements
Your prescriber will need to document your confirmed T2D diagnosis (ICD-10 E11.x), A1c of 6.5% or higher within about 90 days, and a trial or failure of metformin. As a provider-owned New Mexico integrated plan, Presbyterian's internal PA process may differ from national PBM defaults — confirm current criteria with the plan before submission.
- 3
Ask specifically about NM Medicaid if you are on a Presbyterian Medicaid plan
New Mexico Medicaid covers some weight-loss GLP-1s (Wegovy, Zepbound) with PA for eligible enrollees — but this does not extend to Mounjaro, which is a diabetes drug. If you are on a Presbyterian Medicaid plan and have T2D, ask specifically about Mounjaro coverage for diabetes, and verify on the NM Medicaid Preferred Drug List.
Options if Presbyterian Healthcare Services won't cover Mounjaro
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Ozempic (semaglutide)
FDA-approved for type 2 diabetes. Covered with PA across commercial and NM Medicaid plans; often placed ahead of Mounjaro in step-therapy sequences.
Trulicity (dulaglutide)
FDA-approved for T2D. GLP-1 alternative; often preferred tier with a lower list price than Mounjaro. Verify on Presbyterian formulary.
Jardiance (empagliflozin) or Farxiga (dapagliflozin)
SGLT2 inhibitors approved for T2D with cardiovascular and renal benefits. May be included in step-therapy before GLP-1 approval. Verify on Presbyterian formulary.
Zepbound (tirzepatide) — weight loss only
Same molecule as Mounjaro but FDA-approved for chronic weight management and obstructive sleep apnea — not diabetes. Has separate coverage from Mounjaro. NM Medicaid covers Zepbound/Wegovy with PA for weight loss (on-label products); Mounjaro is excluded from weight-loss coverage because it is a diabetes drug.
These options are listed for information only — your own clinician decides what is appropriate for you.
Frequently Asked Questions
No. Presbyterian does not cover Mounjaro for weight loss. Mounjaro is FDA-approved for type 2 diabetes only, and off-label weight-loss prescriptions are denied. The weight-loss tirzepatide product is Zepbound. While NM Medicaid covers some weight-loss GLP-1s (Wegovy, Zepbound) with PA, that coverage does not extend to Mounjaro. Verify any weight-loss GLP-1 coverage on the Presbyterian formulary or through NM Medicaid.
No. New Mexico Medicaid covers some weight-loss GLP-1s (Wegovy and Zepbound) with prior authorization for eligible enrollees — but Mounjaro is diabetes-only and is excluded from weight-loss coverage. If you have type 2 diabetes and are on a Presbyterian NM Medicaid plan, Mounjaro is covered for diabetes with PA. Weight-loss requests coded with obesity diagnoses will be denied regardless of the NM Medicaid weight-loss policy.
Because Presbyterian's drug-level formulary details are not as publicly detailed as national carriers, the most reliable approach is to call Presbyterian member services directly or log in to the member portal. Ask specifically: Is Mounjaro covered for type 2 diabetes? What tier? Is prior authorization required? What is my estimated cost-share? Have your prescriber ready to submit a PA with your T2D diagnosis and A1c documentation.
Yes, if you have commercial Presbyterian coverage and Mounjaro is covered on your plan, you may pay as little as $25/month via the Lilly savings card. Without commercial coverage, the card reduces cost to $499/month (max $647/month, up to 13 fills, expires 12/31/2026). The card is not available to Medicare Part D, Medicare Advantage, Medicaid, or any government program beneficiaries.
No. The 2026 Medicare GLP-1 Bridge ($50/month copay, July 1, 2026 – December 31, 2027) covers weight-loss-approved products only — Wegovy, Foundayo, and the Zepbound KwikPen. Mounjaro is excluded because it is a diabetes drug, not a weight-loss drug. Medicare covers Mounjaro for type 2 diabetes under standard Part D with prior authorization, specialty-tier cost-share, and the $2,100 annual OOP cap.
Related Articles
Does Blue Cross Blue Shield of Michigan Cover Mounjaro? | Curex
BCBS of Michigan covers Mounjaro for type 2 diabetes with PA, not weight loss. Zepbound weight-loss exclusion upheld by MI DIFS in 2025.
Read moreDoes Blue Cross Blue Shield of Minnesota Cover Mounjaro? 2026 | Curex
BCBS of Minnesota covers Mounjaro for type 2 diabetes with PA — not weight loss. MN Medicaid covers weight-loss GLP-1s for Zepbound, not Mounjaro.
Read moreDoes Blue Cross Blue Shield Cover Mounjaro? 2026 Guide | Curex
BCBS covers Mounjaro for type 2 diabetes with prior authorization — not for weight loss. The weight-loss tirzepatide is Zepbound, with separate coverage.
Read moreDoes Blue Cross Blue Shield of Arizona Cover Mounjaro? | Curex
BCBS of Arizona covers Mounjaro for type 2 diabetes with prior auth — not weight loss. AZ Medicaid covers Wegovy for weight loss, but not Mounjaro.
Read moreDoes Presbyterian Healthcare Services Cover Wegovy? | Curex
Presbyterian Healthcare Services covers Wegovy only where your employer opted in; not published. Verify via drug-lookup and confirm with HR.
Read moreDoes Blue Cross Blue Shield of Texas Cover Mounjaro? 2026 | Curex
BCBS of Texas covers Mounjaro for type 2 diabetes with prior auth — not weight loss. The weight-loss tirzepatide is Zepbound, covered separately.
Read moreInsurance covers Mounjaro only for diabetes — for weight loss, here's a path that skips insurance
You just saw how tangled Mounjaro coverage can get — auto-rejections, prior authorization, and high cash prices. Curex compounded semaglutide: $199/month equivalent prepaid annually ($2,388 upfront), or $299/month paid monthly. Compounded tirzepatide: $299/month equivalent prepaid annually ($3,588 upfront), or $399/month paid monthly. Commercial rates as of 2026-10-12; compounded products are not FDA-approved and clinical eligibility must be assessed. Curex compounded medications are not the same as Mounjaro. No insurance or prior authorization required; prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Mounjaro and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Presbyterian Healthcare Services before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Mounjaro and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.